Publications by authors named "M Sae-Hau"
Introduction: Clinical trials are essential for advancing treatment options in oncology while providing cancer patients with innovative care; however, few cancer patients are referred to clinical trials. System-, provider-, and patient-level barriers to clinical trial participation have been described but have not been studied in the Veterans Health Administration (VHA). Although the VHA has engaged in several initiatives to improve Veteran's access to clinical trials, including the National Cancer Institute and VA Interagency Group to Accelerate Trials Enrollment program and VHA work on the White House Cancer Moonshot, further research is needed to understand the multifaceted challenges underlying limited enrollment for Veterans who receive care in the VHA system.
View Article and Find Full Text PDFMyeloma is the third most common blood cancer and one of the most complex and expensive cancers to treat. Black Americans face health disparities related to myeloma incidence, age at diagnosis, access to novel treatments, and mortality. To help reduce health disparities among Black Americans through education and outreach, the Leukemia & Lymphoma Society has implemented its Myeloma Link initiative.
View Article and Find Full Text PDFArticle Synopsis
- - Only a small percentage (5-8%) of adults with cancer participate in clinical trials, especially among underrepresented groups, suggesting that better communication skills by oncologists could help improve these rates.
- - A study was conducted to assess the current state of clinical trial communication training in Hematology-Oncology fellowships, involving surveys and interviews with program directors (PDs). Most PDs acknowledged a lack of training on key CCT communication skills.
- - Results indicate strong interest and feasibility for implementing a communication workshop focused on clinical trials, as PDs believe such training would be beneficial and impactful for future oncologists.
Article Synopsis
- Clinical trial participation for cancer treatment is low, especially among ethnic and racial minority groups, prompting a review to identify successful strategies for increasing enrollment rates.
- The review analyzed 16 studies published between 2012 and 2022 that focused on interventions aimed at overcoming patient and provider barriers and implementing institutional or policy changes.
- Despite identifying themes like patient education and cultural competency, the evidence for effective strategies to increase enrollment remains limited, with few studies providing robust comparative data on accrual rates.
Family caregivers (FCs) of a patient with chronic lymphocytic leukemia (CLL) can encounter unpredictable challenges and care demands. They can experience high levels of burden, a loss of self-care, and poor quality of life. Their receipt of social support and ability to communicate with clinicians may impact their burden.
View Article and Find Full Text PDF